Published in Neurology on September 12, 2012
7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PLoS One (2014) 0.97
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation. Ann Clin Transl Neurol (2014) 0.95
Grey matter damage in multiple sclerosis: a pathology perspective. Prion (2013) 0.93
Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol (2014) 0.92
Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol (2016) 0.84
Myeloid cells - targets of medication in multiple sclerosis. Nat Rev Neurol (2016) 0.83
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis. PLoS One (2013) 0.79
Advanced MRI and staging of multiple sclerosis lesions. Nat Rev Neurol (2016) 0.77
Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. Int J Mol Sci (2017) 0.75
Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter. PLoS One (2014) 0.75
Immune-mediated processes in neurodegeneration: where do we stand? J Neurol (2016) 0.75
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Inflammation in neurodegenerative diseases. Immunology (2010) 3.22
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol (2008) 2.29
A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease. Expert Opin Drug Deliv (2013) 2.13
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Receptor conversion in distant breast cancer metastases. Breast Cancer Res (2010) 1.85
The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol (2005) 1.76
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology (2010) 1.68
Will the real multiple sclerosis please stand up? Nat Rev Neurosci (2012) 1.61
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation (2013) 1.59
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol (2003) 1.55
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol (2010) 1.41
Resting state networks change in clinically isolated syndrome. Brain (2010) 1.41
Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol (2007) 1.40
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain (2008) 1.38
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion (2010) 1.34
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol (2007) 1.32
Inflammation in neurodegenerative diseases--an update. Immunology (2014) 1.30
Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol (2009) 1.29
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol (2009) 1.26
Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging (2006) 1.26
Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology (2006) 1.23
Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur Radiol (2008) 1.22
The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol (2007) 1.20
Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology (2013) 1.20
Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest (2002) 1.19
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases. Cancer (2012) 1.18
Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia (2004) 1.17
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis (2005) 1.14
Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions. J Neuroimmunol (2003) 1.14
A qualitative evaluation of a comprehensive self-management programme for COPD patients: effectiveness from the patients' perspective. Patient Educ Couns (2004) 1.13
Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med (2010) 1.13
Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology (2009) 1.12
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia (2005) 1.12
Post-traumatic cutaneous meningioma. J Laryngol Otol (2004) 1.11
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain (2009) 1.09
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol (2013) 1.08
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler (2011) 1.08
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol (2010) 1.07
Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol (2006) 1.06
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions. Glia (2012) 1.05
Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol (2005) 1.05
Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology (2012) 1.05
Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma. Clin Cancer Res (2007) 1.04
Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol (2013) 1.04
Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol (2011) 1.03
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology (2013) 1.03
In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging (2008) 1.02
Retinoblastoma: MR imaging parameters in detection of tumor extent. Radiology (2005) 1.01
Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy. Epilepsia (2003) 1.01
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography. PLoS One (2012) 1.01
Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology (2010) 1.00
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med (2010) 1.00
Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology (2008) 0.99
Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Hum Brain Mapp (2011) 0.99
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin. Acta Neuropathol (2014) 0.99
Leukaemia cutis: clinical features and treatment strategies. Haematologica (2002) 0.98
Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Lett (2008) 0.97
Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol (2011) 0.96
Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neurother (2012) 0.96
What explains gray matter atrophy in long-standing multiple sclerosis? Radiology (2014) 0.96
CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol (2003) 0.96
Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol (2009) 0.95
Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol (2012) 0.95
Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronization measured using MEG. Neuroimage (2005) 0.94
CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor. Blood (2008) 0.94
Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia (2011) 0.94
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol (2009) 0.93
HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. Arch Neurol (2009) 0.93
Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Hum Brain Mapp (2014) 0.93
Extensive tissue damage of bovine ovaries after bipolar ovarian drilling compared to monopolar electrocoagulation or carbon dioxide laser. Fertil Steril (2008) 0.93
Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology (2014) 0.93
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets (2011) 0.93
Grey matter damage in multiple sclerosis: a pathology perspective. Prion (2013) 0.93
Effect of outpatient exercise training programmes in patients with chronic heart failure: a systematic review. Eur J Prev Cardiol (2012) 0.92
Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv (2013) 0.92
Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler (2011) 0.92
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions. Neurobiol Dis (2009) 0.91
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation (2012) 0.91
Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol (2011) 0.91
Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J Neuropathol Exp Neurol (2015) 0.90
T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun (2009) 0.90